L Carnitine In Omnivorous Diets Induces An Atherogenic Gut Microbial Pathway In Humans

Researchers investigated how L-carnitine, a nutrient abundant in red meat and popular as a supplement, affects cardiovascular health through gut bacteria. They compared what happens when omnivores (meat-eaters) versus vegans and vegetarians consume L-carnitine, tracking how gut bacteria process this compound into various metabolites.

The study revealed a striking difference between dietary groups. When given L-carnitine, omnivores produced more than 20 times the amount of TMAO (trimethylamine N-oxide) compared to vegans and vegetarians. TMAO is a compound that has been linked to increased risk of heart disease, stroke, heart failure, and chronic kidney disease. The researchers discovered that this happens through a multi-step process: gut bacteria first convert L-carnitine to an intermediate compound called γ-butyrobetaine, then to TMA, which the liver finally converts to TMAO.

Importantly, the difference wasn't due to baseline L-carnitine levels in the blood – both groups had similar amounts. Instead, omnivores had developed gut bacteria populations specifically adapted to metabolizing L-carnitine efficiently, likely due to their regular consumption of animal products. When researchers gave participants antibiotics to disrupt their gut bacteria, TMAO production decreased significantly.

This research suggests that your long-term dietary patterns shape your gut microbiome in ways that affect how supplements and nutrients are processed. For patients considering L-carnitine supplementation, this highlights the importance of discussing individual dietary patterns and cardiovascular risk factors with healthcare providers, as the same supplement may have very different metabolic effects depending on your existing gut bacteria composition.